Reducing Alcohol Dependence Among HIV-Positive Individuals
NCT ID: NCT02501057
Last Updated: 2020-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
133 participants
INTERVENTIONAL
2016-08-31
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Unsafe Alcohol Use in HIV-Positive Individuals
NCT00371969
Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV
NCT03652675
HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics
NCT02294318
Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings
NCT02390908
Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care
NCT04280068
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinician's Guide
The Baseline intervention includes a brief meeting (20 minutes or less) with a clinic staff member to discuss drinking and HIV medication adherence. The clinic staff member provides feedback on the participant's drinking, helps the participant set a drinking goal, and make suggestions to help the participant reduce their drinking. Participant receives a booklet called "Rethinking Drinking" that includes information about alcohol and tips for cutting down on alcohol use or quitting drinking. 30- and 60-day visits last about 10 minutes each, and include a meeting with the clinic staff member again to discuss drinking and HIV medication adherence, and to get additional feedback.
Clinician's Guide
An evidence-based, NIAAA-advocated approach to brief intervention for heavy drinking in primary care settings.
Enhanced Motivational Interviewing
Participants meet with a counselor to discuss their alcohol use, the impact it has on their health, and the possibility of reducing their drinking. The first counseling session is intended to help participants reduce their alcohol use. They are asked to describe the pros and cons of their alcohol use and whether it might be important to reduce or quit drinking. After, they are given a study smartphone and asked to use HealthCall-S daily to help keep track of their drinking. At 30 days, participants review a graph showing the results of HealthCall-S use and discuss it with the counselor. They also have a brief discussion about drinking patterns and goals for reduction. They are then asked to continue using HealthCall-S for the next 30 days, after which the counselor meets with the participant for another brief interview to go over the updated graph, and to discuss their experience with HealthCall-S. They will also have a brief discussion about drinking patterns and goals for reduction.
Enhanced Motivational Interviewing
Brief motivational interview plus the use of a smart phone application to monitor alcohol use and health behaviors.
Enhanced Clinician's Guide
Participants in this group receive the Clinician's Guide intervention paired with daily use of HealthCall-S, which includes two cycles of daily use of HealthCall for 30 days, followed by personalized feedback in the form of a graph with a clinic staff member.
Enhanced Clinician's Guide
An evidence-based, NIAAA-advocated approach to brief intervention for heavy drinking in primary care settings plus the use of a smart phone application to monitor alcohol use and health behaviors.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinician's Guide
An evidence-based, NIAAA-advocated approach to brief intervention for heavy drinking in primary care settings.
Enhanced Motivational Interviewing
Brief motivational interview plus the use of a smart phone application to monitor alcohol use and health behaviors.
Enhanced Clinician's Guide
An evidence-based, NIAAA-advocated approach to brief intervention for heavy drinking in primary care settings plus the use of a smart phone application to monitor alcohol use and health behaviors.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient had 4 or more drinks on any day in prior 30 days
* Patient meets criteria for DSM-IV current alcohol dependence
* HIV+
Exclusion Criteria
* Patient has gross cognitive impairment
* Patient does not speak English or Spanish
* Patient has plans to leave the greater New York metropolitan area within the study period
* Patient has vision/hearing impairment that would preclude participation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Research Foundation for Mental Hygiene, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deborah Hasin
Professor of Epidemiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deborah S Hasin, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.